Cargando…
Impact of Body Mass Index on Surgical and Oncological Outcomes in Laparoscopic Total Mesorectal Excision for Locally Advanced Rectal Cancer after Neoadjuvant 5-Fluorouracil-Based Chemoradiotherapy
AIMS: To evaluate the impact of body mass index (BMI) on the surgical outcome of laparoscopic total mesorectal excision (laTME) for locally advanced rectal cancer (LARC, clinically staged as UICC stage II/III) after neoadjuvant chemoradiotherapy (nCRT). METHODS: 312 LARC patients undergoing laTME af...
Autores principales: | Sun, Yanwu, Chi, Pan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618776/ https://www.ncbi.nlm.nih.gov/pubmed/29104590 http://dx.doi.org/10.1155/2017/1509140 |
Ejemplares similares
-
MRI pelvimetry-based evaluation of surgical difficulty in laparoscopic total mesorectal excision after neoadjuvant chemoradiation for male rectal cancer
por: Chen, Jianhua, et al.
Publicado: (2021) -
Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022) -
Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision
por: Ma, Bin, et al.
Publicado: (2016) -
Transanal Total Mesorectal Excision for Rectal Cancer: Perioperative and Oncological Outcomes
por: Hur, Hyuk
Publicado: (2018) -
Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer
por: Maykel, Justin A., et al.
Publicado: (2022)